In addition, data from a transgenic mouse model with human VEGF165 targeted to mammary epithelial cells, indicated that VEGF-A contributes to mammary tumor growth, not only through increased neovascularization, but also by stimulating the proliferation of tumor cells in an autocrine manner, and by inhibiting their apoptosis [77]. Here, VEGFA is linked to neoplasm.